A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B

BACKGROUND/AIMS: Adefovir (ADV) is the preferred drug for treating lamivudine (LAM)-resistant hepatitis B. However, not all patients who face virologic breakthrough during LAM treatment respond to ADV. The aim of this study was to determine the factors associated with efficacy of ADV in LAM-resistan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shin, Su Rin, Koh, Kwang Cheol, Gwak, Geum-Youn, Choi, Moon Seok, Lee, Joon Hyoek, Paik, Seung Woon, Yoo, Byung Chul
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021611/
https://ncbi.nlm.nih.gov/pubmed/21253304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2010.4.4.530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados